activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650747	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1650747	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1650748	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1650749	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3938	Homo sapiens	Kd		
	1650750	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	360.0	CHEMBL3938	Homo sapiens	Kd	uM	0.36
Not Active	1650751	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1650752	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1650753	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1650754	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1650755	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3938	Homo sapiens	Kd		
	1651940	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	200.0	CHEMBL3938	Homo sapiens	Kd	uM	0.2
Not Active	1651941	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1651942	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1651943	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1651944	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL3938	Homo sapiens	Kd		
	1651945	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	510.0	CHEMBL3938	Homo sapiens	Kd	uM	0.51
Not Active	1651946	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1651947	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1651948	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1651949	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL3938	Homo sapiens	Kd		
Not Active	1651950	CHEMBL860783	Average Binding Constant for STK16; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL3938	Homo sapiens	Kd		
	2206868	CHEMBL990543	Inhibition of STK16	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	360.0	CHEMBL3938	Homo sapiens	Kd	nM	360.0
	2470367	CHEMBL981749	Inhibition of STK16 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3938	Homo sapiens	INH	%	10.0
	2476685	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	3.0	CHEMBL3938	Homo sapiens	Activity	%	3.0
Not Evaluated	2476888	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3938	Homo sapiens	Activity		
	2477867	CHEMBL986217	Binding affinity to human MPSK1	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Kd	nM	24.0	CHEMBL3938	Homo sapiens	Kd	nM	24.0
Not Evaluated	2478727	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3938	Homo sapiens	Activity		
	2479549	CHEMBL986217	Binding affinity to human MPSK1	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	>	Kd	nM	40000.0	CHEMBL3938	Homo sapiens	Kd	nM	40000.0
Active	2479785	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3938	Homo sapiens	Activity		
	2480582	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	2.1	CHEMBL3938	Homo sapiens	Activity	%	2.1
Active	2480784	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL3938	Homo sapiens	Activity		
	2577406	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	32.5	CHEMBL3938	Homo sapiens	Activity	%	32.5
	2593611	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	0.5	CHEMBL3938	Homo sapiens	Activity	%	0.5
	2593814	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.1	CHEMBL3938	Homo sapiens	Activity	%	0.1
	2593877	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	2.9	CHEMBL3938	Homo sapiens	Activity	%	2.9
Not Evaluated	2594080	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3938	Homo sapiens	Activity		
Not Evaluated	2595023	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3938	Homo sapiens	Activity		
Not Evaluated	2595292	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3938	Homo sapiens	Activity		
Not Evaluated	2596220	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3938	Homo sapiens	Activity		
	2596423	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	9.9	CHEMBL3938	Homo sapiens	Activity	%	9.9
	2596910	CHEMBL1020555	Inhibition of STK16 assessed as enzyme activity relative to control	B	C[C@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL459769	=	Activity	%	32.0	CHEMBL3938	Homo sapiens	Activity	%	32.0
Active	2597692	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3938	Homo sapiens	Activity		
Not Evaluated	2597895	CHEMBL1025757	Binding affinity to human MPSK1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3938	Homo sapiens	Activity		
	2904061	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904062	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904063	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904064	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904065	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904066	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904067	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904068	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904069	CHEMBL1051353	Binding constant for STK16 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904070	CHEMBL1051353	Binding constant for STK16 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904071	CHEMBL1051353	Binding constant for STK16 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904072	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904073	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904074	CHEMBL1051353	Binding constant for STK16 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904075	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904076	CHEMBL1051353	Binding constant for STK16 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904077	CHEMBL1051353	Binding constant for STK16 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904078	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	360.0	CHEMBL3938	Homo sapiens	Kd	nM	360.0
	2904079	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904080	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	140.0	CHEMBL3938	Homo sapiens	Kd	nM	140.0
	2904081	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904082	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904083	CHEMBL1051353	Binding constant for STK16 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904084	CHEMBL1051353	Binding constant for STK16 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904085	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904086	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	280.0	CHEMBL3938	Homo sapiens	Kd	nM	280.0
	2904087	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904088	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904089	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904090	CHEMBL1051353	Binding constant for STK16 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904091	CHEMBL1051353	Binding constant for STK16 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904092	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904093	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	270.0	CHEMBL3938	Homo sapiens	Kd	nM	270.0
	2904094	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	730.0	CHEMBL3938	Homo sapiens	Kd	nM	730.0
	2904095	CHEMBL1051353	Binding constant for STK16 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	250.0	CHEMBL3938	Homo sapiens	Kd	nM	250.0
	2904096	CHEMBL1051353	Binding constant for STK16 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	610.0	CHEMBL3938	Homo sapiens	Kd	nM	610.0
	2904097	CHEMBL1051353	Binding constant for STK16 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2904098	CHEMBL1051353	Binding constant for STK16 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	2922006	CHEMBL1056156	Inhibition of STK16 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3938	Homo sapiens	Activity	%	100.0
	3052501	CHEMBL1072539	Residual activity of TSF1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	102.0	CHEMBL3938	Homo sapiens	Residual activity	%	102.0
	3052753	CHEMBL1043832	Residual activity of TSF1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	96.0	CHEMBL3938	Homo sapiens	Residual activity	%	96.0
	3054062	CHEMBL1073361	Residual activity of TSF1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	59.0	CHEMBL3938	Homo sapiens	Residual activity	%	59.0
	3055349	CHEMBL1072539	Residual activity of TSF1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	100.0	CHEMBL3938	Homo sapiens	Residual activity	%	100.0
	3055601	CHEMBL1043832	Residual activity of TSF1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	90.0	CHEMBL3938	Homo sapiens	Residual activity	%	90.0
	3056906	CHEMBL1073361	Residual activity of TSF1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	66.0	CHEMBL3938	Homo sapiens	Residual activity	%	66.0
	3057158	CHEMBL1072539	Residual activity of TSF1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL3938	Homo sapiens	Residual activity	%	93.0
	3058478	CHEMBL1043832	Residual activity of TSF1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	87.0	CHEMBL3938	Homo sapiens	Residual activity	%	87.0
	3059762	CHEMBL1073361	Residual activity of TSF1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	56.0	CHEMBL3938	Homo sapiens	Residual activity	%	56.0
	3203244	CHEMBL1103000	Inhibition of STK16	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	230.0	CHEMBL3938	Homo sapiens	Kd	uM	0.23
	3332161	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3333576	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3334981	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3336401	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3337656	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3338987	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3339243	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3340546	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3341943	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3343390	CHEMBL1167709	Inhibition of STK16 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	3351767	CHEMBL1175023	Inhibition of STK16 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	47.0	CHEMBL3938	Homo sapiens	INH	%	47.0
	3358819	CHEMBL1175023	Inhibition of STK16 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL3938	Homo sapiens	INH	%	100.0
	3448634	CHEMBL1244987	Binding affinity to STK16	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	3448791	CHEMBL1244987	Binding affinity to STK16	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	19.0	CHEMBL3938	Homo sapiens	Kd	nM	19.0
	3449056	CHEMBL1244987	Binding affinity to STK16	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	280.0	CHEMBL3938	Homo sapiens	Kd	nM	280.0
	3449349	CHEMBL1244987	Binding affinity to STK16	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	250.0	CHEMBL3938	Homo sapiens	Kd	nM	250.0
	3449861	CHEMBL1244987	Binding affinity to STK16	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	3450250	CHEMBL1244987	Binding affinity to STK16	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
	3451156	CHEMBL1244987	Binding affinity to STK16	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	uM	10.0
Not Active	3499145	CHEMBL1259889	Inhibition of STK16 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL3938	Homo sapiens	INH		
	3603128	CHEMBL1291225	Inhibition of STK16 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	9.0	CHEMBL3938	Homo sapiens	Inihibition	%	9.0
	5120199	CHEMBL1648822	Inhibition of STK16 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	21.0	CHEMBL3938	Homo sapiens	INH	%	21.0
	5120226	CHEMBL1648822	Inhibition of STK16 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	38.0	CHEMBL3938	Homo sapiens	INH	%	38.0
	5123822	CHEMBL1645766	Inhibition of STK16 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	99.0	CHEMBL3938	Homo sapiens	INH	%	99.0
	5126363	CHEMBL1646104	Inhibition at STK16 at 10 uM relative to control	B	CCNc1nc2sc(-c3cccc([C@H](C)NC(C)=O)c3)nc2c2c1ncn2C		CHEMBL1642546	=	Inhibition	%	10.0	CHEMBL3938	Homo sapiens	INH	%	10.0
	5127513	CHEMBL1646104	Inhibition at STK16 at 10 uM relative to control	B	CC(=O)N[C@@H](C)c1cccc(-c2nc3c(nc(N)c4ncn(C)c43)s2)c1		CHEMBL1642547	=	Inhibition	%	10.0	CHEMBL3938	Homo sapiens	INH	%	10.0
	5139716	CHEMBL1648822	Inhibition of STK16 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1	Outside typical range	CHEMBL1644642	=	Inhibition	%	-28.0	CHEMBL3938	Homo sapiens	INH	%	-28.0
	5139717	CHEMBL1648822	Inhibition of STK16 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1	Outside typical range	CHEMBL1644639	=	Inhibition	%	-18.0	CHEMBL3938	Homo sapiens	INH	%	-18.0
	5139730	CHEMBL1648822	Inhibition of STK16 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	-9.0	CHEMBL3938	Homo sapiens	INH	%	-9.0
	5139765	CHEMBL1648822	Inhibition of STK16 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	-1.0	CHEMBL3938	Homo sapiens	INH	%	-1.0
	5249452	CHEMBL1686803	Inhibition of STK16 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	29.0	CHEMBL3938	Homo sapiens	INH	%	29.0
	6221268	CHEMBL1787830	Inhibition of STK16 at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	0.0	CHEMBL3938	Homo sapiens	INH	%	0.0
	6339888	CHEMBL1826087	Activity of STK16 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	43.0	CHEMBL3938	Homo sapiens	Activity	%	43.0
	6385643	CHEMBL1837988	Inhibition of human MPSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	6385644	CHEMBL1837988	Inhibition of human MPSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	6385645	CHEMBL1837988	Inhibition of human MPSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	6385646	CHEMBL1837988	Inhibition of human MPSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	6385647	CHEMBL1837988	Inhibition of human MPSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	7567169	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7567628	CHEMBL1908472	Binding constant for STK16 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7568099	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7568567	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	4800.0	CHEMBL3938	Homo sapiens	Kd	nM	4800.0
	7568999	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	250.0	CHEMBL3938	Homo sapiens	Kd	nM	250.0
	7569142	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7569602	CHEMBL1908472	Binding constant for STK16 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7570074	CHEMBL1908472	Binding constant for STK16 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	490.0	CHEMBL3938	Homo sapiens	Kd	nM	490.0
	7571118	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	1100.0	CHEMBL3938	Homo sapiens	Kd	nM	1100.0
	7571575	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7572051	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	18.0	CHEMBL3938	Homo sapiens	Kd	nM	18.0
	7572072	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7572488	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	800.0	CHEMBL3938	Homo sapiens	Kd	nM	800.0
	7573099	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	18.0	CHEMBL3938	Homo sapiens	Kd	nM	18.0
	7573556	CHEMBL1908472	Binding constant for STK16 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7574059	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	280.0	CHEMBL3938	Homo sapiens	Kd	nM	280.0
	7574467	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	540.0	CHEMBL3938	Homo sapiens	Kd	nM	540.0
	7575077	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7575567	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7576032	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	1900.0	CHEMBL3938	Homo sapiens	Kd	nM	1900.0
	7576440	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	6.6	CHEMBL3938	Homo sapiens	Kd	nM	6.6
	7577051	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7577068	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7577546	CHEMBL1908472	Binding constant for STK16 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	29.0	CHEMBL3938	Homo sapiens	Kd	nM	29.0
	7578016	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	4000.0	CHEMBL3938	Homo sapiens	Kd	nM	4000.0
	7578421	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7578617	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7579441	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7579915	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7580384	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7580787	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	610.0	CHEMBL3938	Homo sapiens	Kd	nM	610.0
	7580975	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7581360	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7581805	CHEMBL1908472	Binding constant for STK16 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7582276	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	2500.0	CHEMBL3938	Homo sapiens	Kd	nM	2500.0
	7582740	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1.7	CHEMBL3938	Homo sapiens	Kd	nM	1.7
	7583140	CHEMBL1908472	Binding constant for STK16 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7583321	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7583718	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7584163	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	1100.0	CHEMBL3938	Homo sapiens	Kd	nM	1100.0
	7584634	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7585096	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7585651	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7586059	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7586505	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7586976	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7587612	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	370.0	CHEMBL3938	Homo sapiens	Kd	nM	370.0
	7588031	CHEMBL1908472	Binding constant for STK16 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	19.0	CHEMBL3938	Homo sapiens	Kd	nM	19.0
	7588484	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	7300.0	CHEMBL3938	Homo sapiens	Kd	nM	7300.0
	7588964	CHEMBL1908472	Binding constant for STK16 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7589577	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7590001	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1500.0	CHEMBL3938	Homo sapiens	Kd	nM	1500.0
	7590468	CHEMBL1908472	Binding constant for STK16 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7590500	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7590951	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7591550	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7591972	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7592475	CHEMBL1908472	Binding constant for STK16 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7592928	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7593517	CHEMBL1908472	Binding constant for STK16 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7593982	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7594455	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7594907	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7595487	CHEMBL1908472	Binding constant for STK16 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7595961	CHEMBL1908472	Binding constant for STK16 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7596432	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	360.0	CHEMBL3938	Homo sapiens	Kd	nM	360.0
	7596879	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	270.0	CHEMBL3938	Homo sapiens	Kd	nM	270.0
	7597015	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7597468	CHEMBL1908472	Binding constant for STK16 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7597941	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7598411	CHEMBL1908472	Binding constant for STK16 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3938	Homo sapiens	Kd	nM	10000.0
	7598853	CHEMBL1908472	Binding constant for STK16 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	730.0	CHEMBL3938	Homo sapiens	Kd	nM	730.0
	7969760	CHEMBL1931459	Inhibition of MSK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	75.0	CHEMBL3938	Homo sapiens	Activity	%	75.0
	7996726	CHEMBL1944378	Inhibition of STK16 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	97.0	CHEMBL3938	Homo sapiens	INH	%	97.0
	7996764	CHEMBL1944378	Inhibition of STK16 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	91.0	CHEMBL3938	Homo sapiens	INH	%	91.0
	8003584	CHEMBL1942751	Inhibition of human MPSK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	8003585	CHEMBL1942751	Inhibition of human MPSK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	8003586	CHEMBL1942751	Inhibition of human MPSK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	8003587	CHEMBL1942751	Inhibition of human MPSK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	8046123	CHEMBL1959400	Inhibition of STK16 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	=	Inhibition	%	87.0	CHEMBL3938	Homo sapiens	INH	%	87.0
	10839652	CHEMBL2016297	Inhibition of MPSK1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	102.0	CHEMBL3938	Homo sapiens	Activity	%	102.0
	10840379	CHEMBL2015165	Inhibition of MPSK1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	96.0	CHEMBL3938	Homo sapiens	Activity	%	96.0
	12170773	CHEMBL2209900	Inhibition of MPSK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	105.0	CHEMBL3938	Homo sapiens	Activity	%	105.0
	12170904	CHEMBL2213463	Inhibition of MPSK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	102.0	CHEMBL3938	Homo sapiens	Activity	%	102.0
	12172196	CHEMBL2209689	Inhibition of STK16 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL3938	Homo sapiens	Activity	%	86.0
	12183812	CHEMBL2214449	Inhibition of STK16	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	pIC50		5.0
	12668219	CHEMBL2339637	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	40.0	CHEMBL3938	Homo sapiens	INH	%	40.0
	12668220	CHEMBL2339637	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	84.0	CHEMBL3938	Homo sapiens	INH	%	84.0
	12668221	CHEMBL2339637	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	84.0	CHEMBL3938	Homo sapiens	INH	%	84.0
	12668222	CHEMBL2339637	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	85.0	CHEMBL3938	Homo sapiens	INH	%	85.0
	12668223	CHEMBL2339637	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	44.0	CHEMBL3938	Homo sapiens	INH	%	44.0
	12668224	CHEMBL2339637	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1	Outside typical range	CHEMBL2333128	=	Inhibition	%	-47.0	CHEMBL3938	Homo sapiens	INH	%	-47.0
	12668225	CHEMBL2339637	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	39.0	CHEMBL3938	Homo sapiens	INH	%	39.0
	12672969	CHEMBL2339711	Inhibition of recombinant MPSK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	28.0	CHEMBL3938	Homo sapiens	Activity	%	28.0
	12672970	CHEMBL2339711	Inhibition of recombinant MPSK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	36.0	CHEMBL3938	Homo sapiens	Activity	%	36.0
	12723639	CHEMBL2350470	Inhibition of STK16 (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1	Outside typical range	CHEMBL2347818	=	Inhibition	%	-24.0	CHEMBL3938	Homo sapiens	INH	%	-24.0
	12723682	CHEMBL2350777	Inhibition of STK16 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	10.0	CHEMBL3938	Homo sapiens	INH	%	10.0
	12723683	CHEMBL2350777	Inhibition of STK16 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	3.0	CHEMBL3938	Homo sapiens	INH	%	3.0
	13374338	CHEMBL2405669	Inhibition of STK16 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	9.0	CHEMBL3938	Homo sapiens	INH	%	9.0
	13438284	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438285	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438286	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438287	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438288	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438289	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438290	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438291	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438292	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438293	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	13438294	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	=	Inhibition	%	39.1	CHEMBL3938	Homo sapiens	INH	%	39.1
	13438295	CHEMBL2422457	Inhibition of MPSK1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	=	Inhibition	%	48.9	CHEMBL3938	Homo sapiens	INH	%	48.9
	13439924	CHEMBL2429306	Competitive binding affinity to STK16 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	13442438	CHEMBL2429306	Competitive binding affinity to STK16 (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL3938	Homo sapiens	INH	%	85.0
	13442474	CHEMBL2429167	Binding affinity to STK16 (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	450.0	CHEMBL3938	Homo sapiens	Kd	uM	0.45
	13445434	CHEMBL2429306	Competitive binding affinity to STK16 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL3938	Homo sapiens	INH	%	100.0
	13448489	CHEMBL2429306	Competitive binding affinity to STK16 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	81.0	CHEMBL3938	Homo sapiens	INH	%	81.0
	13448623	CHEMBL2429306	Competitive binding affinity to STK16 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	93.0	CHEMBL3938	Homo sapiens	INH	%	93.0
	13451418	CHEMBL2429306	Competitive binding affinity to STK16 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	83.0	CHEMBL3938	Homo sapiens	INH	%	83.0
	13454605	CHEMBL2429306	Competitive binding affinity to STK16 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	15072584	CHEMBL3388692	Inhibition of MPSK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	113.0	CHEMBL3938	Homo sapiens	Activity	%	113.0
	15151386	CHEMBL3395601	Inhibition of STK16 (unknown origin) at 0.1 uM	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1		CHEMBL3393333	>	Inhibition	%	80.0	CHEMBL3938	Homo sapiens	INH	%	80.0
	15188667	CHEMBL3411308	Inhibition of human STK16 using MBP substrate, ATP and [gamma33P]ATP at 1 uM	B	Cc1c[nH]c2ncnc(-c3ccc(NC(=O)N(CCO)c4ccccc4)cc3)c12		CHEMBL3410036	>=	Inhibition	%	80.0	CHEMBL3938	Homo sapiens	INH	%	80.0
	15250381	CHEMBL3430285	Binding affinity to human STK16 at 10 uM relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Activity	%	92.0	CHEMBL3938	Homo sapiens	Activity	%	92.0
	15258379	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	6.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	6.0
	15258439	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.7
	15258499	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	1.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.7
	15258559	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	5.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	5.6
	15258619	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	3.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.5
	15258679	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	4.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.7
	15258739	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.6
	15258799	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15258859	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	4.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.4
	15258919	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	7.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	7.4
	15258979	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	2.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.9
	15259039	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	5.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	5.5
	15259099	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	3.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.0
	15259159	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	11.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	11.7
	15259219	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	7.8	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	7.8
	15259279	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	1.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.7
	15259339	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-1.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-1.2
	15259399	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	-0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259459	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.1
	15259519	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	-0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259579	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	-0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259639	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	-0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259699	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.8	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.8
	15259759	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	3.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.3
	15259819	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15259879	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15259939	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	0.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.0
	15259999	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	1.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.9
	15260059	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	0.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.6
	15260119	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.0
	15260179	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15260239	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	1.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.9
	15260299	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	3.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.4
	15260359	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	8.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	8.7
	15260419	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	1.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.4
	15260479	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-1.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-1.2
	15260539	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	2.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.9
	15260599	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	2.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.3
	15260659	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15260719	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15260779	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15260839	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
Not Determined	15260899	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605		Thermal melting change			CHEMBL3938	Homo sapiens	Thermal melting change		
Not Determined	15260959	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Thermal melting change			CHEMBL3938	Homo sapiens	Thermal melting change		
Not Determined	15261019	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Thermal melting change			CHEMBL3938	Homo sapiens	Thermal melting change		
Not Determined	15261079	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940		Thermal melting change			CHEMBL3938	Homo sapiens	Thermal melting change		
	15261139	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	3.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.1
	15261162	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15261222	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15261282	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	1.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.1
	15261342	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.1
	15261457	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15261517	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.0
	15261577	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	11.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	11.5
	15261637	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261650	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.9
	15261710	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15261770	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15261830	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	4.8	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.8
	15261890	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	4.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.3
	15261946	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15262006	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15262066	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15262126	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	4.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.5
	15262199	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.7
	15262259	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	1.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.0
	15262319	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	3.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.9
	15262379	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15262439	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	1.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.1
	15262499	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	2.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.6
	15262559	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	1.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.0
	15262619	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.6
	15262679	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15262739	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15262799	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.1
	15262859	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.1
	15262919	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	2.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.6
	15262979	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	1.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.7
	15263039	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.7
	15263099	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	1.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.0
	15263159	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15263219	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15263279	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.1
	15263339	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	1.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.0
	15263435	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	7.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	7.6
	15263490	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15263550	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	6.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	6.9
	15263610	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	1.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.5
	15263670	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	3.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.1
	15263744	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.6
	15263804	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	1.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.1
	15263864	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.6
	15263924	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	1.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.9
	15263978	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	10.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	10.7
	15264038	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	5.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	5.4
	15264098	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264158	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15264218	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15264231	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	1.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.0
	15264291	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	7.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	7.5
	15264351	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	1.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.1
	15264411	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	0.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.9
	15264527	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	5.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	5.1
	15264587	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	2.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.3
	15264647	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15264707	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15264719	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	1.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.5
	15264779	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	3.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.2
	15264839	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15264899	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	3.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.5
	15264959	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	3.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.1
	15265015	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15265075	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	0.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.7
	15265135	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15265195	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	1.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.7
	15265268	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	2.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.6
	15265328	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.7
	15265388	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	1.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.2
	15265448	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	2.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.3
	15265504	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15265564	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15265624	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15265684	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15265756	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15265816	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.8	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.8
	15265876	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15265936	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.6
	15265993	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15266053	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	4.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.4
	15266113	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15266173	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	1.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.9
	15266245	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	0.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.7
	15266305	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266365	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15266425	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	4.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.3
	15266480	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	4.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.9
	15266540	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	1.7	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.7
	15266600	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	2.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	2.1
	15266660	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	4.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.3
	15266733	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	4.8	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.8
	15266793	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.2
	15266853	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	4.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	4.4
	15266913	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.3
	15266968	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	3.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.5
	15267028	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	3.9	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	3.9
	15267088	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	1.2	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.2
	15267148	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	1.3	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.3
	15267221	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	1.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	1.1
	15267281	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	6.8	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	6.8
	15267341	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15267401	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	0.5	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.5
	15267456	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	9.6	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	9.6
	15267516	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	-0.4
	15267576	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.0	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.0
	15267636	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.4	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.4
	15267696	CHEMBL3430838	Delta TM value showing the stabilisation of MPSK1 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.1	CHEMBL3938	Homo sapiens	Thermal melting change	degrees C	0.1
	15728405	CHEMBL3624246	Inhibition of STK16 (unknown origin) at 10 uM	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	>	Inhibition	%	90.0	CHEMBL3938	Homo sapiens	INH	%	90.0
	15756807	CHEMBL3631479	Inhibition of STK16 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-19.94	CHEMBL3938	Homo sapiens	INH	%	-19.94
	15757916	CHEMBL3631479	Inhibition of STK16 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	7.44	CHEMBL3938	Homo sapiens	INH	%	7.44
	15758895	CHEMBL3631479	Inhibition of STK16 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-17.95	CHEMBL3938	Homo sapiens	INH	%	-17.95
	16425374	CHEMBL3751218	Inhibition of STK16 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	11.0	CHEMBL3938	Homo sapiens	INH	%	11.0
	16432011	CHEMBL3750165	Inhibition of human STK16 using MBP substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	uM	10.0
	16451616	CHEMBL3761197	Inhibition of STK16 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	29.5	CHEMBL3938	Homo sapiens	INH	%	29.5
	16612600	CHEMBL3815486	Inhibition of human MPSK1 (1 to 305 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-4.0	CHEMBL3938	Homo sapiens	Activity	%	-4.0
	16614635	CHEMBL3816851	Inhibition of human STK16 at 1 uM using MBP substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	3.0	CHEMBL3938	Homo sapiens	INH	%	3.0
	16654235	CHEMBL3829769	Inhibition of human MPSK1 (1 to 305 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	87.0	CHEMBL3938	Homo sapiens	Activity	%	87.0
Inactive	17940991	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940992	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940993	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17940994	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1243.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	1243.0
Inactive	17940995	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940996	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940997	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940998	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940999	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941000	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941001	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941002	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941003	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941004	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941005	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941006	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941007	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941008	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Kd	nM	9969.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	9969.0
Inactive	17941009	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941010	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941011	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941012	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941013	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941014	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941015	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941016	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941017	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941018	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941019	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941020	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941021	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941022	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941023	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941024	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941025	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941026	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941027	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941028	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941029	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941030	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941031	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941032	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941033	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941034	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941035	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941036	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941037	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941038	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941039	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941040	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941041	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941042	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	1867.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	1867.0
Inactive	17941043	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941044	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941045	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941046	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941047	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941048	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941049	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941050	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941051	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941052	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941053	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941054	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941055	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941056	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941057	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	849.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	849.0
Inactive	17941058	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941059	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941060	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941061	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941062	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941063	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941064	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941065	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941066	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941067	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941068	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941069	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941070	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	566.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	566.0
Inactive	17941071	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941072	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941073	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941074	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941075	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941076	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941077	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941078	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941079	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941080	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941081	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941082	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941083	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941084	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941085	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941086	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941087	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941088	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941089	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941090	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941091	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941092	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941093	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941094	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941095	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941096	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941097	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941098	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941099	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941100	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941101	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941102	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941103	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941104	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941105	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941106	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941107	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941108	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941109	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941110	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941111	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941112	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941113	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941114	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941115	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941116	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941117	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941118	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	210.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	210.0
Inactive	17941119	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941120	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941121	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941122	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17941123	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	8337.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	8337.0
Inactive	17941124	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941125	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941126	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941127	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941128	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941129	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941130	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1281.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	1281.0
Inactive	17941131	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941132	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941133	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941134	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941135	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941136	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941137	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941138	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941139	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	893.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	893.0
Inactive	17941140	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941141	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941142	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	702.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	702.0
Inactive	17941143	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941144	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	855.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	855.0
Inactive	17941145	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941146	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941147	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941148	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941149	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941150	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941151	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941152	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941153	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941154	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941155	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941156	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941157	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941158	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941159	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941160	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941161	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	2484.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	2484.0
Inactive	17941162	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941163	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941164	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1095.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	1095.0
Inactive	17941165	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941166	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	95.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	95.0
Inactive	17941167	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941168	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941169	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941170	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	2013.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	2013.0
Inactive	17941171	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941172	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941173	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941174	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941175	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941176	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941177	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	495.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	495.0
Inactive	17941178	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941179	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941180	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941181	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941182	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941183	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941184	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941185	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941186	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941187	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	1281.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	1281.0
Inactive	17941188	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941189	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	186.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	186.0
Inactive	17941190	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941191	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941192	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941193	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941194	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941195	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941196	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941197	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941198	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941199	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941200	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941201	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941202	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941203	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941204	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941205	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941206	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	138.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	138.0
Uncertain	17941207	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	515.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	515.0
Inactive	17941208	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941209	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941210	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941211	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941212	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941213	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941214	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941215	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941216	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941217	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941218	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941219	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941220	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941221	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941222	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941223	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941224	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941225	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941226	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	295.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	295.0
Inactive	17941227	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941228	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941229	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941230	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941231	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941232	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	30000.0
Active	17941233	CHEMBL3991892	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	5446.0	CHEMBL3938	Homo sapiens	Kd apparent	nM	5446.0
	18007232	CHEMBL4003440	Inhibition of full length human GST-tagged TSF1 expressed in Sf9 cells assessed as residual activity at 1 uM relative to control	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1		CHEMBL4082278	=	Activity	%	10.0	CHEMBL3938	Homo sapiens	Activity	%	10.0
Active	18021266	CHEMBL4005842	Inhibition of human STK16 (11 to 305 amino acid residues) expressed in bacterial expression system at 1 uM in presence of [gamma-33P]-ATP by KINOMEscan assay	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cn2)n1		CHEMBL4081497		Inhibition	%		CHEMBL3938	Homo sapiens	INH		
	18031868	CHEMBL4007747	Inhibition of STK16 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	885.0	CHEMBL3938	Homo sapiens	IC50	uM	0.885
	18031869	CHEMBL4007747	Inhibition of STK16 (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	=	IC50	nM	4500.0	CHEMBL3938	Homo sapiens	IC50	uM	4.5
	18114866	CHEMBL4025396	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL3938	Homo sapiens	Activity	%	99.0
	18147991	CHEMBL4032838	Inhibition of TSF1 (unknown origin) at 10 uM after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting	B	N#Cc1ccc2c(c1)[nH]c(=O)n2[C@H]1C[C@H](c2nnc(-c3ccncn3)n2-c2ccccc2Cl)C1		CHEMBL4095003	=	Inhibition	%	52.0	CHEMBL3938	Homo sapiens	INH	%	52.0
	18203920	CHEMBL4044207	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3938	Homo sapiens	Activity	%	100.0
	18232239	CHEMBL4050422	Inhibition of human MPSK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	118.0	CHEMBL3938	Homo sapiens	Activity	%	118.0
	18253523	CHEMBL4055045	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	85.0	CHEMBL3938	Homo sapiens	Activity	%	85.0
	18253524	CHEMBL4055045	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	87.0	CHEMBL3938	Homo sapiens	Activity	%	87.0
	18282189	CHEMBL4120144	Inhibition of recombinant full length His-tagged human STK16 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	50.3	CHEMBL3938	Homo sapiens	INH	%	50.3
	18282224	CHEMBL4120179	Inhibition of recombinant full length His-tagged human STK16 expressed in baculovirus expression system by FRET assay	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	IC50	nM	1520.0	CHEMBL3938	Homo sapiens	IC50	uM	1.52
	18282508	CHEMBL4120144	Inhibition of recombinant full length His-tagged human STK16 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	33.2	CHEMBL3938	Homo sapiens	INH	%	33.2
	18440462	CHEMBL4157286	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	61.0	CHEMBL3938	Homo sapiens	Activity	%	61.0
	18449897	CHEMBL4178131	Inhibition of human MPSK1 (1 to 305 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	99.0	CHEMBL3938	Homo sapiens	Activity	%	99.0
	18484418	CHEMBL4186065	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	77.0	CHEMBL3938	Homo sapiens	Activity	%	77.0
	18484902	CHEMBL4186065	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	77.0	CHEMBL3938	Homo sapiens	Activity	%	77.0
	18653347	CHEMBL4230232	Inhibition of STK16 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	8.0	CHEMBL3938	Homo sapiens	INH	%	8.0
	18653348	CHEMBL4230232	Inhibition of STK16 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL3938	Homo sapiens	INH	%	2.0
	18655270	CHEMBL4230965	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	88.0	CHEMBL3938	Homo sapiens	Activity	%	88.0
	18751246	CHEMBL4263955	Inhibition of STK16 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	58.0	CHEMBL3938	Homo sapiens	INH	%	58.0
	18752217	CHEMBL4264554	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	76.0	CHEMBL3938	Homo sapiens	Activity	%	76.0
	18850842	CHEMBL4305764	Binding affinity to biotinylated STK16 (unknown origin) incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based binding displacement assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	IC50	nM	20000.0	CHEMBL3938	Homo sapiens	IC50	uM	20.0
	18850843	CHEMBL4305764	Binding affinity to biotinylated STK16 (unknown origin) incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based binding displacement assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Ki	nM	11900.0	CHEMBL3938	Homo sapiens	Ki	uM	11.9
	18858217	CHEMBL4308063	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL3938	Homo sapiens	Activity	%	99.0
	18892974	CHEMBL4314940	Inhibition of human STK16 assessed as residual activity at 10 uM by radiometric method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	101.5	CHEMBL3938	Homo sapiens	Activity	%	101.5
	18919564	CHEMBL4322920	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged STK16 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	365.0	CHEMBL3938	Homo sapiens	Kd	nM	365.0
	18919752	CHEMBL4322920	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged STK16 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	110.0	CHEMBL3938	Homo sapiens	Kd	nM	110.0
	18938317	CHEMBL4327885	Inhibition of human STK16 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	93.14	CHEMBL3938	Homo sapiens	Activity	%	93.14
	18938318	CHEMBL4327885	Inhibition of human STK16 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.86	CHEMBL3938	Homo sapiens	Activity	%	96.86
	18938730	CHEMBL4328249	Inhibition of human STK16 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3938	Homo sapiens	Activity	%	65.0
	18939116	CHEMBL4328613	Inhibition of human STK16 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	235.0	CHEMBL3938	Homo sapiens	IC50	10'-7M	2.35
	18958989	CHEMBL4333645	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	85.0	CHEMBL3938	Homo sapiens	Activity	%	85.0
	18964714	CHEMBL4335298	Inhibition of human STK16 assessed as residual activity at 1 uM by radiometric method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	95.0	CHEMBL3938	Homo sapiens	Activity	%	95.0
	18964715	CHEMBL4335298	Inhibition of human STK16 assessed as residual activity at 1 uM by radiometric method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	90.0	CHEMBL3938	Homo sapiens	Activity	%	90.0
	18972113	CHEMBL4337123	Inhibition of human STK16 assessed as residual activity at 10 uM in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	59.0	CHEMBL3938	Homo sapiens	Activity	%	59.0
	19009172	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CC1		CHEMBL4516665	=	Ki	nM	330.0	CHEMBL3938	Homo sapiens	Ki	nM	330.0
	19009173	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452360	=	Ki	nM	350.0	CHEMBL3938	Homo sapiens	Ki	nM	350.0
	19009174	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4534959	=	Ki	nM	91.0	CHEMBL3938	Homo sapiens	Ki	nM	91.0
	19009175	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	=	Ki	nM	310.0	CHEMBL3938	Homo sapiens	Ki	nM	310.0
	19009176	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CC(C)CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4571548	=	Ki	nM	78.0	CHEMBL3938	Homo sapiens	Ki	nM	78.0
	19009177	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCCS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4552310	=	Ki	nM	110.0	CHEMBL3938	Homo sapiens	Ki	nM	110.0
	19009178	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccc(F)cc4)c3)ccc12)C1CC1		CHEMBL4534571	=	Ki	nM	430.0	CHEMBL3938	Homo sapiens	Ki	nM	430.0
	19009179	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccccc4F)c3)ccc12)C1CC1		CHEMBL4473140	=	Ki	nM	470.0	CHEMBL3938	Homo sapiens	Ki	nM	470.0
	19009180	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4cccc(F)c4)c3)ccc12)C1CC1		CHEMBL4593649	=	Ki	nM	510.0	CHEMBL3938	Homo sapiens	Ki	nM	510.0
	19009181	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CCC4)c3)ccc12)C1CC1		CHEMBL4535040	=	Ki	nM	240.0	CHEMBL3938	Homo sapiens	Ki	nM	240.0
	19009182	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CCC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4447403	=	Ki	nM	180.0	CHEMBL3938	Homo sapiens	Ki	nM	180.0
	19009183	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CN(CC(F)(F)F)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4561238	=	Ki	nM	290.0	CHEMBL3938	Homo sapiens	Ki	nM	290.0
	19009184	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4582326	=	Ki	nM	180.0	CHEMBL3938	Homo sapiens	Ki	nM	180.0
	19009185	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CC(C)CS(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4522276	=	Ki	nM	450.0	CHEMBL3938	Homo sapiens	Ki	nM	450.0
	19009186	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(CC)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4472438	=	Ki	nM	220.0	CHEMBL3938	Homo sapiens	Ki	nM	220.0
	19009187	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4542463	=	Ki	nM	150.0	CHEMBL3938	Homo sapiens	Ki	nM	150.0
	19009188	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(C)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4470026	=	Ki	nM	86.0	CHEMBL3938	Homo sapiens	Ki	nM	86.0
	19009189	CHEMBL4345186	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged STK16 kinase domain (13 to 305 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	=	Ki	nM	270.0	CHEMBL3938	Homo sapiens	Ki	nM	270.0
	19009238	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CC1		CHEMBL4516665	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009239	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009240	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CC(C)CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4571548	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009241	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCCS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4552310	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009242	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccc(F)cc4)c3)ccc12)C1CC1		CHEMBL4534571	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009243	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccccc4F)c3)ccc12)C1CC1		CHEMBL4473140	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009244	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4cccc(F)c4)c3)ccc12)C1CC1		CHEMBL4593649	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009245	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CCC4)c3)ccc12)C1CC1		CHEMBL4535040	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009246	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CCC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4447403	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009247	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CN(CC(F)(F)F)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4561238	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009248	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4582326	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009249	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CC(C)CS(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4522276	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009250	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(CC)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4472438	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009251	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4542463	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009252	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(C)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4470026	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
	19009253	CHEMBL4345190	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused STK16 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	nM	10000.0
Not Active	19040171	CHEMBL4352072	Inhibition of human STK16 at 10 uM by radiometric method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3938	Homo sapiens	INH		
Active	19041288	CHEMBL4352549	Inhibition of human STK16 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3938	Homo sapiens	INH		
	19059842	CHEMBL4358143	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3938	Homo sapiens	Activity	%	100.0
	19090406	CHEMBL4365980	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	77.0	CHEMBL3938	Homo sapiens	Activity	%	77.0
	19092124	CHEMBL4366598	Inhibition of human STK16 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.3	CHEMBL3938	Homo sapiens	INH	%	-2.3
	19148050	CHEMBL4379446	Inhibition of human STK16 in presence of 10 uM ATP by radiometric analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3938	Homo sapiens	IC50	uM	10.0
	19159670	CHEMBL4382774	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	64.0	CHEMBL3938	Homo sapiens	Activity	%	64.0
	19181148	CHEMBL4387359	Inhibition of tracer 236 binding to recombinant full length human His-tagged STK16 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	91.5	CHEMBL3938	Homo sapiens	INH	%	91.5
	19181373	CHEMBL4387359	Inhibition of tracer 236 binding to recombinant full length human His-tagged STK16 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	29.5	CHEMBL3938	Homo sapiens	INH	%	29.5
	19191337	CHEMBL4389493	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	18.0	CHEMBL3938	Homo sapiens	INH	%	18.0
	19192156	CHEMBL4389970	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	82.0	CHEMBL3938	Homo sapiens	INH	%	82.0
	19200412	CHEMBL4391596	Binding affinity to wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	1.9	CHEMBL3938	Homo sapiens	Activity	%	1.9
	19266623	CHEMBL4405573	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	19485784	CHEMBL4481509	Binding affinity to C-terminal AVI-tagged STK16 (unknown origin) (13 to 305 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Ki	nM	51000.0	CHEMBL3938	Homo sapiens	Ki	uM	51.0
	19485785	CHEMBL4481509	Binding affinity to C-terminal AVI-tagged STK16 (unknown origin) (13 to 305 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(Nc2cc(C)nc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4518437	>	Ki	nM	100000.0	CHEMBL3938	Homo sapiens	Ki	uM	100.0
	19485786	CHEMBL4481509	Binding affinity to C-terminal AVI-tagged STK16 (unknown origin) (13 to 305 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395	=	Ki	nM	15000.0	CHEMBL3938	Homo sapiens	Ki	uM	15.0
	22392169	CHEMBL4667264	Inhibition of tracer 236 binding to recombinant human His-tagged full length STK16 expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.0	CHEMBL3938	Homo sapiens	INH	%	3.0
	22423229	CHEMBL4674190	Inhibition of human STK16 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	89.02	CHEMBL3938	Homo sapiens	Activity	%	89.02
	22423230	CHEMBL4674190	Inhibition of human STK16 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	80.62	CHEMBL3938	Homo sapiens	Activity	%	80.62
	22843560	CHEMBL4720546	Inhibition of human STK16 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	242.0	CHEMBL3938	Homo sapiens	IC50	10^-7M	2.42
	22843903	CHEMBL4720889	Inhibition of human STK16 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.63	CHEMBL3938	Homo sapiens	Activity	%	97.63
	22844870	CHEMBL4721545	Inhibition of wild-type human partial length STK16 (G11 to I305 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	98.67	CHEMBL3938	Homo sapiens	Activity	%	98.67
	22845464	CHEMBL4721745	Binding affinity to Nluc-tagged STK16 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	2.45	CHEMBL3938	Homo sapiens	deltaTm	degrees C	2.45
	22915618	CHEMBL4735394	Inhibition of wild-type human partial length TSF1 (G11 to I305 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4ccccc4F)c3)ccc12		CHEMBL4752141	=	Activity	%	33.0	CHEMBL3938	Homo sapiens	Activity	%	33.0
	23120698	CHEMBL4804433	Inhibition of MPSK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-28800.0	CHEMBL3938	Homo sapiens	IC50	uM	-28.8
	23120699	CHEMBL4804433	Inhibition of MPSK1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-9100.0	CHEMBL3938	Homo sapiens	IC50	uM	-9.1
	23120700	CHEMBL4804433	Inhibition of MPSK1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	100.0	CHEMBL3938	Homo sapiens	IC50	uM	0.1
	23120701	CHEMBL4804433	Inhibition of MPSK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	43900.0	CHEMBL3938	Homo sapiens	IC50	uM	43.9
	23120702	CHEMBL4804433	Inhibition of MPSK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	72800.0	CHEMBL3938	Homo sapiens	IC50	uM	72.8
	23120703	CHEMBL4804433	Inhibition of MPSK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	55200.0	CHEMBL3938	Homo sapiens	IC50	uM	55.2
	23121737	CHEMBL4804615	Inhibition of MPSK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3938	Homo sapiens	INH	%	0.0
	23121738	CHEMBL4804615	Inhibition of MPSK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3938	Homo sapiens	INH	%	0.0
	23121739	CHEMBL4804615	Inhibition of MPSK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3938	Homo sapiens	INH	%	0.0
	23121740	CHEMBL4804615	Inhibition of MPSK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	35.0	CHEMBL3938	Homo sapiens	INH	%	35.0
	23121741	CHEMBL4804615	Inhibition of MPSK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	50.0	CHEMBL3938	Homo sapiens	INH	%	50.0
	23122827	CHEMBL4805178	Inhibition of human STK16 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	71.0	CHEMBL3938	Homo sapiens	Activity	%	71.0
	23123522	CHEMBL4805766	Inhibition of human STK16 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	83.0	CHEMBL3938	Homo sapiens	Activity	%	83.0
	23123974	CHEMBL4806218	Inhibition of DNA-tagged human STK16 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	89.0	CHEMBL3938	Homo sapiens	Activity	%	89.0
	23125134	CHEMBL4806783	Inhibition of human STK16 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL3938	Homo sapiens	Activity	%	80.0
	23125135	CHEMBL4806783	Inhibition of human STK16 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	87.0	CHEMBL3938	Homo sapiens	Activity	%	87.0
	23128665	CHEMBL4808030	Inhibition of TSF1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3938	Homo sapiens	Activity	%	75.0
	23128666	CHEMBL4808030	Inhibition of TSF1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3938	Homo sapiens	Activity	%	75.0
	23128667	CHEMBL4808030	Inhibition of TSF1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3938	Homo sapiens	Activity	%	75.0
	23195912	CHEMBL4819727	Inhibition of human STK16 at 100 nM by direct-filter Binding radiometric assay relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	=	Inhibition	%	87.0	CHEMBL3938	Homo sapiens	INH	%	87.0
Not Active	23227194	CHEMBL4825790	Inhibition of human STK16 at 0.1 uM relative to control	B	N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4S(=O)(=O)C(F)(F)F)c3)ncc2F)cn1		CHEMBL4864387		Inhibition	%		CHEMBL3938	Homo sapiens	INH		
Active	23238832	CHEMBL4828666	Inhibition of human wild type partial length STK16 (G11 to I305 residues) expressed in bacterial expression system at 1 uM measured by Kinomescan method	B	Cn1ncc2cc(-c3cnc4[nH]nc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21		CHEMBL4877883		Inhibition	%		CHEMBL3938	Homo sapiens	INH		
	23238834	CHEMBL4828668	Inhibition of human wild type partial length STK16 (G11 to I305) expressed in bacterial expression system by Kinomescan method	B	Cn1ncc2cc(-c3cnc4[nH]nc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21		CHEMBL4877883	=	IC50	nM	107.0	CHEMBL3938	Homo sapiens	IC50	nM	107.0
	23239308	CHEMBL4828833	Inhibition of ADP(ATP)-biotin probe binding to MPSK1 in human Kelly cells at 1 uM incubated for 6 hrs by KiNativ profiling analysis	B	CN(C)C/C=C/C(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1		CHEMBL4754873	=	Inhibition	%	42.4	CHEMBL3938	Homo sapiens	INH	%	42.4
Not Active	23317663	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	97.0	CHEMBL3938	Homo sapiens	% Control	%	97.0
Not Active	23318131	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	84.0	CHEMBL3938	Homo sapiens	% Control	%	84.0
Not Active	23318797	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	99.0	CHEMBL3938	Homo sapiens	% Control	%	99.0
Not Active	23319281	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	99.0	CHEMBL3938	Homo sapiens	% Control	%	99.0
Not Active	23319917	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23320393	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23321071	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	87.0	CHEMBL3938	Homo sapiens	% Control	%	87.0
Not Active	23321539	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23322169	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	72.0	CHEMBL3938	Homo sapiens	% Control	%	72.0
Not Active	23322637	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	87.0	CHEMBL3938	Homo sapiens	% Control	%	87.0
Not Active	23323326	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	81.0	CHEMBL3938	Homo sapiens	% Control	%	81.0
Not Active	23323794	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23324648	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23325283	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	85.0	CHEMBL3938	Homo sapiens	% Control	%	85.0
Not Active	23325751	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	89.0	CHEMBL3938	Homo sapiens	% Control	%	89.0
Not Active	23326398	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	95.0	CHEMBL3938	Homo sapiens	% Control	%	95.0
Not Active	23326866	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23327566	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	88.0	CHEMBL3938	Homo sapiens	% Control	%	88.0
Not Active	23328034	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	99.0	CHEMBL3938	Homo sapiens	% Control	%	99.0
Not Active	23328621	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23329089	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	83.0	CHEMBL3938	Homo sapiens	% Control	%	83.0
Not Active	23329536	CHEMBL4881243	STK16(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	99.0	CHEMBL3938	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23330035	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23330503	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23331259	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23331727	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23332314	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	64.3	CHEMBL3938	Homo sapiens	% Control	%	64.3
Not Active	23332780	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	53.9	CHEMBL3938	Homo sapiens	% Control	%	53.9
Not Active	23333498	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	84.6	CHEMBL3938	Homo sapiens	% Control	%	84.6
Not Active	23334137	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	97.0	CHEMBL3938	Homo sapiens	% Control	%	97.0
Not Active	23334605	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23335584	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	87.0	CHEMBL3938	Homo sapiens	% Control	%	87.0
Not Active	23336052	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23336679	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23337147	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	80.0	CHEMBL3938	Homo sapiens	% Control	%	80.0
Not Active	23337781	CHEMBL4882152	STK16 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.0	CHEMBL3938	Homo sapiens	% Ctrl	%	98.0
Not Active	23338228	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23338696	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23339308	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23339776	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	91.0	CHEMBL3938	Homo sapiens	% Control	%	91.0
Not Active	23340413	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	93.0	CHEMBL3938	Homo sapiens	% Control	%	93.0
Not Active	23340881	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	99.0	CHEMBL3938	Homo sapiens	% Control	%	99.0
Not Active	23341538	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23342006	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23342622	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23343090	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23343720	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	78.0	CHEMBL3938	Homo sapiens	% Control	%	78.0
Not Active	23344188	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	86.0	CHEMBL3938	Homo sapiens	% Control	%	86.0
Not Active	23344826	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	92.0	CHEMBL3938	Homo sapiens	% Control	%	92.0
Not Active	23345399	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23345867	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	79.0	CHEMBL3938	Homo sapiens	% Control	%	79.0
Not Active	23346444	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23346912	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	78.0	CHEMBL3938	Homo sapiens	% Control	%	78.0
Not Active	23347512	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	60.3	CHEMBL3938	Homo sapiens	% Control	%	60.3
Not Active	23348004	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23348583	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23349051	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23349638	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	97.0	CHEMBL3938	Homo sapiens	% Control	%	97.0
Not Active	23350256	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23350724	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23351329	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	99.0	CHEMBL3938	Homo sapiens	% Control	%	99.0
Not Active	23351797	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	95.0	CHEMBL3938	Homo sapiens	% Control	%	95.0
Not Active	23352233	CHEMBL4882922	STK16 (PKL12) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.585	CHEMBL3938	Homo sapiens	% Inhibition	%	2.5852
Not Active	23352821	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23353289	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23354171	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23354639	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23355371	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23355839	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23356475	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23356943	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23357552	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23358199	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	90.0	CHEMBL3938	Homo sapiens	% Control	%	90.0
Not Active	23358667	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	98.0	CHEMBL3938	Homo sapiens	% Control	%	98.0
Not Active	23359253	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	87.2	CHEMBL3938	Homo sapiens	% Control	%	87.2
Not Active	23359851	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23360319	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	85.0	CHEMBL3938	Homo sapiens	% Control	%	85.0
Not Active	23360904	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	92.0	CHEMBL3938	Homo sapiens	% Control	%	92.0
Not Active	23361372	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23361945	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	92.0	CHEMBL3938	Homo sapiens	% Control	%	92.0
Not Active	23362481	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	91.0	CHEMBL3938	Homo sapiens	% Control	%	91.0
Not Active	23362949	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23364591	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	79.0	CHEMBL3938	Homo sapiens	% Control	%	79.0
Not Active	23365059	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	91.0	CHEMBL3938	Homo sapiens	% Control	%	91.0
Not Active	23365798	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL3938	Homo sapiens	% Control	%	92.0
Not Active	23366341	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL3938	Homo sapiens	% Control	%	95.0
Not Active	23366931	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23367399	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23367769	CHEMBL4884122	TSF1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	94.0	CHEMBL3938	Homo sapiens	% Residual activity with Skepinone-L	%	94.0
Not Active	23368277	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23368745	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23369344	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	86.0	CHEMBL3938	Homo sapiens	% Control	%	86.0
Not Active	23369812	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23370780	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	79.0	CHEMBL3938	Homo sapiens	% Control	%	79.0
Not Active	23371248	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	83.0	CHEMBL3938	Homo sapiens	% Control	%	83.0
Not Active	23372057	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23372525	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
	23373744	CHEMBL4885521	MPSK1(ST16LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3938	Homo sapiens	pIC50		6.0
Not Active	23375105	CHEMBL4886093	STK16 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	15.0	CHEMBL3938	Homo sapiens	% Inhibition	%	15.0
Not Active	23375952	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	93.0	CHEMBL3938	Homo sapiens	% Control	%	93.0
Not Active	23376420	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	91.0	CHEMBL3938	Homo sapiens	% Control	%	91.0
Not Active	23376997	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	83.0	CHEMBL3938	Homo sapiens	% Control	%	83.0
Not Active	23377465	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	83.0	CHEMBL3938	Homo sapiens	% Control	%	83.0
Not Active	23378325	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	84.0	CHEMBL3938	Homo sapiens	% Control	%	84.0
Not Active	23378793	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	99.0	CHEMBL3938	Homo sapiens	% Control	%	99.0
Not Active	23379960	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23380428	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23381122	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	88.0	CHEMBL3938	Homo sapiens	% Control	%	88.0
Not Active	23381770	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Not Active	23382238	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
Active	23382862	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	7.7	CHEMBL3938	Homo sapiens	% Control	%	7.7
Active	23383330	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	1.5	CHEMBL3938	Homo sapiens	% Control	%	1.5
Not Active	23383996	CHEMBL4887597	STK16 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	91.0	CHEMBL3938	Homo sapiens	% Ctrl	%	91.0
Not Active	23384473	CHEMBL4888068	STK16(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	9.54	CHEMBL3938	Homo sapiens	% inhibition	%	9.54
Not Active	23385245	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	75.0	CHEMBL3938	Homo sapiens	% Control	%	75.0
Not Active	23385712	CHEMBL4879969	KinomeScan assay: inhibition of STK16	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3938	Homo sapiens	% Control	%	100.0
